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Many of us have contemplated decisions about our health like whether or not to 
have the flu vaccine, whether or not be screened for breast or prostate cancer, or 
whether or not to have surgery for lower back pain. Patients with end-stage kidney 
disease face a number of important health and treatment decisions such as: Should I 
have a transplant? Should I be keep taking statins? Should I go on dialysis? The 
answers to these questions are not straightforward because they depend on a 
multitude of factors including clinical indications, availability of the treatment 
options, potential harms and benefits of each treatment, and alignment of the 
treatment options with patients’ values, goals and beliefs. The process of shared 
decision making1 brings together evidence-based decisions about healthcare and 
informed decisions about patients’ lives, to create shared decisions about health, 
illness, treatment and care delivery.2 Informed decision-making on the other hand, is 
slightly different in that it refers to making decisions based on accurate information, 
which can be made independently, and/or with family members, and/or with staff 
providing that care. 
 
Several studies report people with advanced kidney disease are dissatisfied with the 
amount and type of information they receive about dialysis treatment options.3 A 
systematic review of patients’ perspectives about treatment option information 
found 10 of 18 studies in which patients and family members felt they had 
insufficient information on which to make informed treatment decisions.3 
Furthermore, many patients found the timing of information provision to be 
problematic, as it often occurred when they were acutely unwell and unable to make 
best use of the information, or it was delivered just as a decision needed to be made, 
causing a rushed, time-pressured decision.3,4 Patients with advanced kidney disease 
and their families, who are naïve to the world of dialysis, and who carry varying 
degrees of health literacy, rely on accurate information from health professionals 
about peritoneal dialysis and haemodialysis treatments in order to make informed 
choices. Patient decision aids are one evidence-based method to achieve this.5 
 
Decision aids in healthcare are designed to encourage patients and clinicians to 
consider information about treatment options and their consequences, evaluate this 
information in accord with their values, make a decision accounting for trade-offs 
and discuss this reasoning with others to agree upon and implement a preferred 
choice.5 A recent PubMed search identified >460 hits for ‘dialysis decision aid’, 
including eight patient decision aids listed for a variety of chronic kidney disease 
health decisions, with five of those relevant to dialysis modality decision making;(My 
Kidneys, My Choice [Australia];6 Dialysis: Making the right choices for you – the 
dialysis decision aid booklet YoDDA[UK];2,7  Kidney failure: What type of dialysis 
should I have[US];7 My Life, My Dialysis Choice [US]; and Chronic kidney disease: 
Treatment Options[UK]. 
 
Winterbottom and colleagues2 recently evaluated their decision aid, Dialysis: Making 
the right choices for you – the dialysis decision aid booklet (also known as the 
Yorkshire Dialysis Decision Aid (YoDDA)), in a prospective non-randomised study 
among 189 participants. Importantly this evaluation was undertaken from two 
perspectives: i) patients making dialysis treatment decisions and ii) implementation 
of the decision aid into usual practice, in a busy and varied group of renal units 
which would be considered representative of many units in the UK.  
 
Briefly, the YoDDA decision aid is a booklet that contains information about chronic 
kidney disease, conservative care and renal replacement therapy; differences 
between specific dialysis options; and a decision-attribute summary table that 
prompts a patient rating of whether centre-based haemodialysis, home 
haemodialysis, continuous ambulatory peritoneal dialysis or automated peritoneal 
dialysis best fits their lifestyle at the current point in time. The final section is a 
glossary with useful additional links for support. A number of countries have 
translated the YoDDA booklet into their own lauguage. 
http://www.kidneyresearchuk.org/file/health-information/kr-decision-aid-colour.pdf 
 
The prospective study by Winterbottom et al.2 compared usual pre-dialysis care for 
newly referred patients at six Yorkshire renal services between February - August 
2012, to usual care plus the YoDDA booklet, for patients referred between 
September 2012 - March 2013. The main outcomes from the patient perspective 
were the usefulness of written information; decision making processes; and 
decisional conflict measured at the initial pre-dialysis consultation and then again six 
weeks later. Acceptability of the decision aid from a health service perspective was 
measured by the proportion of new patients at each centre who were given the 
YoDDA booklet intervention; and the number of centres continuing  to hand out 
YoDDA booklets following study completion.  
 
The main findings showed that at six weeks, those in the YoDDA intervention group 
had significantly higher information scores, higher decision clarity and feelings of 
control, and higher levels of shared decision making among their family. Importantly, 
the YoDDA significantly improved patients’ considerations of the advantages and 
disadvantages of each option (including harms and benefits of each dialysis 
modality). YoDDA improved all measures of autonomy in decision-making although 
this difference was not statistically significant. Preparedness for decision making 
scores were higher in the YoDDA group compared to the usual care group directly 
following the pre-dialysis education and six weeks later. Interestingly, there was no 
difference between YoDDA and usual care groups in decisional conflict, which the 
authors interpreted as participants not experiencing conflict and /or the measure 
used (decisional conflict scale) was not sensitive to detecting decisional uncertainty. 
In contrast to other studies,3,8 the YoDDA evaluation found the views of family and 
professionals were important in treatment decision-making, but not the views of 
other patients. Forty-five percent of referred patients in the intervention group were 
given the YoDDA booklet with a by-center variation of 14%-49%. Four of six centres 
continued giving out YoDDA booklets after the study closed.2  
 
Some important limitations of the YODDA evaluation are worth mentioning. The 
study was not randomized and therefore subject to selection bias, whereby 
characteristics of participants in the usual care and YoDDA groups may be different. 
There was a moderate amount of missing data (as evidenced by a <60% survey 
completion rate for both groups at initial consultation and six weeks); and 
potentially a larger sample size may have been needed to confirm evidence of effect 
in some of the measured outcomes.  
 
 
However, the authors are to be commended for their study evaluating the 
acceptability and usefulness of a dialysis decision aid. YoDDA itself was developed 
through an extensive, systematic process that included reviews of clinical guidelines, 
service frameworks and analysis of existing patient information; using decision 
analysis and behavioural decision support guidance; and testing face validity. It is 
well grounded in decision-making theory, and was designed with an emphasis on 
removing ‘dialysis modality biases’ from the information presented.2 This type of 
decision aid evaluation is rarely undertaken and published.  
 
 
Implementation of the decision aid into usual practice 
Perhaps one of the greatest strengths of this study is the knowledge it generates 
about a complex health service intervention and the explicit evaluation of study 
engagement by health professionals and the feasibility of incorporating this decision 
aid into current practice. The authors reported a variation in the rate of uptake of 
YoDDA across the six renal units, and proposed reasons for this including a limited 
health service infrastructure, differing views towards research about shared decision 
making, or possibly limited benefits of dialysis decision aids for patients with 
worsening health.2 Either way, these reasons for a lack of engagement are 
interesting and important, as they may speak to something broader about the 
judgments made by health professionals on behalf of new patients. In one sense this 
represents a ‘gatekeeper’ effect, where health professionals act as information 
agents, and ‘control’ the type of information being delivered.9 This can have both 
positive and negative consequences including the avoidance of ‘information 
overload’ to anxious or overwhelmed patients by delivering the right amount of 
information at the right time, or it may lead to a lack of information provision about 
all available courses of action. The fact that YoDDA is now directly accessible through 
consumer organisations like Kidney Research UK, may help overcome this barrier.  
 
A Cochrane review of decision aids for people facing treatment or screening 
decisions,5 found high-quality evidence that decision aids compared to usual care 
improved people’s knowledge regarding options, and reduce their decisional conflict 
related to feeling uninformed and unclear about their personal values. There was 
moderate-quality evidence that decision aids compared to usual care stimulated 
people to take a more active role in decision making, and improved accurate risk 
perceptions when probabilities were included in decision aids, compared to not 
being included. There was low-quality evidence that decision aids improved 
congruence between the chosen option and the patient’s values.  
 
Other health service benefits of dialysis decision aids have been reported.  
Decision aids can change service provider behavior and this is a fundamental 
contribution to improvements in patient care. Fortnum et al,10 in an implementation 
study of the My Kidneys, My Choice decision aid, claims that staff variations in pre-
dialysis education practices were minimized through staff training in shared decision 
making and implementation of the decision aid. Further changes may be uncovered 
such as the nature of conversations with patients, through a process evaluation 
study, with benefits to be gained by health services just as much as by patients.  
 
Returning to the main question posed in the title – do decision aids improve 
decision-making? There is good evidence that YoDDA helps patients think differently 
about the problem of choosing between treatment for advanced kidney disease. Of 
equal benefit I would argue is that the use of a decision aid like YoDDA also helps 
clinicians think differently about the treatment they recommend for individual 
patients. 
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Note: The Ottawa hospital – Research Institute maintains a list of available patient 
decision aids with a quality assessment of each according to International Patient 
Decision Aid Standards (IPDAS). (https://decisionaid.ohri.ca/AZlist.html) 
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